Product Images Breztri
View Photos of Packaging, Labels & Appearance
- Budesonide Chemical Structure - budesonidechemstructure
- carton - container
- Figure 1 - figure1
- Formoterol Fumarate Chemical Structure - formoterolfumaratechemstructure
- Glycopyrrolate Chemical Structure - glycopyrrolatechemstructure
- Figure 1 - cartridge - image 01
- Figure 2a, 2b, 2c - dose indicators - image 02
- Figure 2d - dose indicator diaplay changes color - image 03
- Figure 3 - priming your inhaler - image 04
- Figure 4 - press down - image 05
- Figure 5 - release a puff of medicine - image 06
- Figure 6 - remove the cap - image 07
- Figure 7 - shake inhaler - image 08
- Figure 8 - breathe out - image 09
- Figure 9 - close your lips - image 10
- Figure 10 - breathe in deeply and slowly - image 11
- Figure 11 - hold your breath - image 12
- Figure 12 - breath out gently - image 13
- Figure 13 - replace the cap - image 14
- Figure 14 - good and bad air flow - image 15
- Figure 15 - take canister out - image 16
- Figure 16 - hold under running warm water - image 17
- Figure 17 - leave air-dry over night - image 18
- Figure 18 - when dry gently press canister into actuator - image 19
Product Label Images
The following 24 images provide visual information about the product associated with Breztri NDC 0310-4616 by Astrazeneca Pharmaceuticals Lp, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Budesonide Chemical Structure - budesonidechemstructure
carton - container
This is a medication packaging with dosing instructions and precautions. It is a combination of three active ingredients, budesonide, glycopyrrolate, and formoterol fumarate, intended for inhalation. The medication is prescribed for the treatment of respiratory conditions. However, the dosing instructions also caution against the use of the inhaler beyond three months of initial use or after the date of pouch opening. The product is distributed by AstraZeneca, with a National Drug Code of 30-481 for restricted use by prescription only.*
Figure 1 - figure1
Formoterol Fumarate Chemical Structure - formoterolfumaratechemstructure
Glycopyrrolate Chemical Structure - glycopyrrolatechemstructure
This is not a complete text and cannot be evaluated.*
Figure 1 - cartridge - image 01
The text describes a figure, which may depict an inhaler, with a side view and a top view. The figure includes a dose indicator with a display window and a pointer, a canister, an actuator, a mouthpiece, and a cap. The text suggests that the inhaler is used for medication administration.*
Figure 2a, 2b, 2c - dose indicators - image 02
Figure 2d - dose indicator diaplay changes color - image 03
Figure 3 - priming your inhaler - image 04
Not available.*
Figure 4 - press down - image 05
Figure 5 - release a puff of medicine - image 06
Figure 6 - remove the cap - image 07
Figure 7 - shake inhaler - image 08
Figure 8 - breathe out - image 09
Figure 9 - close your lips - image 10
Figure 10 - breathe in deeply and slowly - image 11
Figure 11 - hold your breath - image 12
Figure 12 - breath out gently - image 13
Figure 13 - replace the cap - image 14
Figure 14 - good and bad air flow - image 15
Figure 15 - take canister out - image 16
Figure 16 - hold under running warm water - image 17
Figure 17 - leave air-dry over night - image 18
Figure 18 - when dry gently press canister into actuator - image 19
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
